Showing results (481-490 of 574) with videos related to

Sort By:
Pageof 58
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severityL S Haug, A C Ostvold, R F Cowburn, et al.
Neuroscience Letters|February 28, 1994
Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish familyL Lannfelt, N Bogdanovic, H Appelgren, et al.
Acta Neurologica Scandinavica|May 1, 1989
Neurotransmitter deficits in a non-multi-infarct category of vascular dementiaA Wallin, I Alafuzoff, A Carlsson, et al.
Neurochemistry International|May 25, 2010
Transmitter deficits in Alzheimer's diseaseJ Hardy, R Adolfsson, I Alafuzoff, et al.
Neurology|July 13, 2006
Elevated cortical zinc in Alzheimer diseaseD Religa, D Strozyk, R A Cherny, et al.
Archives of Neurology|June 16, 1999
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of diseaseN Andreasen, C Hesse, P Davidsson, et al.
Neurochemical Research|August 10, 2001
The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defenseE Karelson, N Bogdanovic, A Garlind, et al.
Neurobiology of Aging|August 5, 2000
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's diseaseV Jelic, S E Johansson, O Almkvist, et al.
Neurology|October 3, 2007
Education and dementia: what lies behind the association?T Ngandu, E von Strauss, E-L Helkala, et al.
Neurobiology of Aging|May 1, 1987
Divergent changes in D-1 and D-2 dopamine binding sites in human brain during agingD G Morgan, J O Marcusson, P Nyberg, et al.
Pageof 58